Royal Bank of Canada’s Acutus Medical Inc AFIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-252
| Closed | – | – | 7758 |
|
|
2024
Q1 | $0 | Sell |
252
-123
| -33% | -$24 | ﹤0.01% | 7793 |
|
|
2023
Q4 | $0 | Buy |
375
+158
| +73% | +$62 | ﹤0.01% | 7762 |
|
|
2023
Q3 | $0 | Sell |
217
-22
| -9% | -$14 | ﹤0.01% | 7791 |
|
|
2023
Q2 | $0 | Buy |
239
+157
| +191% | +$133 | ﹤0.01% | 7809 |
|
|
2023
Q1 | $0 | Sell |
82
-193
| -70% | -$252 | ﹤0.01% | 7637 |
|
|
2022
Q4 | $0 | Buy |
275
+206
| +299% | +$170 | ﹤0.01% | 7908 |
|
|
2022
Q3 | $0 | Buy |
+69
| New | +$84 | ﹤0.01% | 8029 |
|
|
2022
Q2 | – | Sell |
-12,174
| Closed | -$17K | – | 7861 |
|
|
2022
Q1 | $17K | Buy |
12,174
+6,780
| +126% | +$14.5K | ﹤0.01% | 6700 |
|
|
2021
Q4 | $18K | Sell |
5,394
-338
| -6% | -$1.9K | ﹤0.01% | 6850 |
|
|
2021
Q3 | $51K | Buy |
5,732
+1,989
| +53% | +$26.2K | ﹤0.01% | 6154 |
|
|
2021
Q2 | $64K | Buy |
3,743
+2,047
| +121% | +$29.9K | ﹤0.01% | 5875 |
|
|
2021
Q1 | $23K | Buy |
1,696
+948
| +127% | +$21.3K | ﹤0.01% | 6351 |
|
|
2020
Q4 | $21K | Buy |
748
+248
| +50% | +$6.71K | ﹤0.01% | 6049 |
|
|
2020
Q3 | $15K | Buy |
+500
| New | +$15.2K | ﹤0.01% | 5804 |
|
Other funds holding AFIB
Royal Bank of Canada's AFIB Position: Q2 2024 in Review
Royal Bank of Canada sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 252 shares.
Royal Bank of Canada first reported a position in AFIB in Q3 2020 and held it in 14 quarters. The position peaked at $64K in Q2 2021. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.
- Royal Bank of Canada reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
- Royal Bank of Canada sold 252 Acutus Medical Inc shares in Q2 2024.
- Royal Bank of Canada first reported a position in Acutus Medical Inc in Q3 2020 and held it in 14 quarters.
- Royal Bank of Canada's Acutus Medical Inc position peaked at $64K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.
Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.